Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome.
Gordon C S Smith, Imran Shah, Jennifer A Crossley...
https://pubmed.ncbi.nlm.nih.gov/16394054/Actively Recruiting
Led by Makerere University · Updated on 2026-09-28
4000
Participants Needed
2
Research Sites
N/A
Total Duration
Pregnancy complications such as pre-eclampsia, poor fetal growth, unexplained stillbirth, and spontaneous preterm birth are major causes of illness and death for mothers and babies in sub-Saharan Africa. These conditions, known as the Great Obstetrical Syndromes GOS, are linked to problems with placenta development early in pregnancy. This study aims to investigate clinical, biological, and social factors associated with these complications in a prospective cohort of Ugandan women, using advanced methods including artificial intelligence to identify risk patterns and improve prediction. The study will enroll 4,000 first-time pregnant women under 18 weeks gestation from two hospitals in Kampala, Uganda. Participants will be followed throughout their pregnancy until delivery, attending routine visits at 20, 28, and 36 weeks gestation. At these visits, data on health, pregnancy progress, and social circumstances will be collected through physical exams, ultrasound scans, and blood and urine samples. At delivery, additional samples will be taken from the mother, baby, umbilical cord, and placenta for research and future studies. Participants will be monitored closely with clinical examinations, blood pressure and urine protein tests, and biomarker analysis during pregnancy. The study will measure outcomes including the development of pre-eclampsia, spontaneous preterm birth, fetal growth restriction, and stillbirth. Data will be securely collected and analyzed using statistical and AI methods to understand risk factors and improve screening. Follow-up care will continue as usual after delivery, with participant safety and data privacy prioritized throughout the study, which is expected to conclude by October 2026.
CONDITIONS
Enhancing Prediction of Adverse Pregnancy Outcomes in Africa Through Partnerships and Innovation
A
Annettee Olivia Nakimuli, MBChB, MMED, MBA, PhD
M
Moses Adroma, MBChB, MMED
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Makerere University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening visit including ultrasound to confirm pregnancy age and viability
Duration - From enrollment until delivery (approximately up to 9 months)
Participants attend study visits at 20, 28, and 36 weeks gestation for health assessments, ultrasound scans, and blood and urine sample collection. Data on pregnancy progress and social factors are collected. Participants continue routine prenatal care alongside study visits.
3 scheduled visits during pregnancy
Duration - Delivery day
At delivery, research staff collect detailed information on labor, delivery, and newborn outcomes. Blood, placental, and cord samples are taken for research purposes with additional consent.
1 visit at delivery
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Gordon C S Smith, Imran Shah, Jennifer A Crossley...
https://pubmed.ncbi.nlm.nih.gov/16394054/WHO Alliance for Maternal and Newborn Health Improvement Late Pregnancy Dating Study Group
https://pubmed.ncbi.nlm.nih.gov/32199122/Joy E Lawn, Hannah Blencowe, Shefali Oza...
https://pubmed.ncbi.nlm.nih.gov/24853593/Zarko Alfirevic, Tamara Stampalija, Nancy Medley
https://pubmed.ncbi.nlm.nih.gov/25874722/Jane Weiler, Stephen Tong, Kirsten R Palmer
https://pubmed.ncbi.nlm.nih.gov/22046419/Annettee Nakimuli, Olympe Chazara, Josaphat Byamugisha...
https://pubmed.ncbi.nlm.nih.gov/24184340/O Jonasson, M A Hardy
https://pubmed.ncbi.nlm.nih.gov/3906160/Arvind Goel, Sarosh Rana
https://pubmed.ncbi.nlm.nih.gov/24076553/David M Haas, Deborah B Ehrenthal, Matthew A Koch...
https://pubmed.ncbi.nlm.nih.gov/26825925/Ivo Brosens, Robert Pijnenborg, Lisbeth Vercruysse...
https://pubmed.ncbi.nlm.nih.gov/21094932/Makerere University
Lead Sponsor